In a social media post, SASAC( State-owned Assets Supervision and Administration Commission of the State Council) has broadcast, “Chinese-made coronavirus vaccine could be ready for market as early as the end of this year.”
When the trial was held, more than 2,000 people received vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products.
According to the post on Chinese social media platform WeChat, “A vaccine could be ready for the market as early as the end of this year or early 2021.” Finally, vaccines have entered Phase II clinical trials made in the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. Both groups are joined with state-owned pharmaceutical group Sinopharm, whose management is overseen by SASAC.
As per the article posted, “The Beijing Institute of Biological Products’ production line will have an annual manufacturing capacity of 100 million to 120 million doses.”
Though China has five coronavirus vaccines in human trials but neither of the company was able to comment.